Insiders Medivir AB

Equities

Delayed Nasdaq Stockholm Other stock markets 06:46:15 2024-04-30 am EDT			5-day change	1st Jan Change
3.16 ^SEK	-0.63%		+14.49%	+10.88%

Apr. 25	Medivir Gets Two US FDA Designations for MIV-711	MT
Mar. 21	Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024.	CI

Medivir AB Appoints Nomination Committee	23-10-23	CI
Medivir AB Announces Resignation of Anette Lindqvist as Director	23-10-20	CI
Medivir AB Announces Formation of A Scientific Advisory Council	23-08-07	CI
Medivir's New Chief Medical Officer Takes Office	23-02-21	MT
Medivir AB Appoints Pia Baumann as Chief Medical Officer	23-02-21	CI
Medivir Appoints Former AstraZeneca VP As Chief Medical Officer	22-11-21	MT
Medivir AB Appoints Pia Baumann as New Chief Medical Officer	22-11-21	CI
Medivir AB Appoints Nomination Committee	22-10-28	CI
Nomination Committee of Medivir appointed	22-10-28	AQ
Medivir Aktiebolag Announces Board Changes	22-05-05	CI
InDex Pharmaceuticals Names New Chief Development Officer, Chief Medical Officer	22-05-02	MT
Medivir's Newly Appointed CEO To Take Office	22-01-17	MT
Jens Lindberg Takes Office as CEO of Medivir AB on January 24	22-01-17	CI
Medivir AB Appoints Jenens Lindberg as New CEO	21-11-03	CI
Nomination Committee of Medivir appointed	21-10-28	AQ
Medivir AB Appoints Nomination Committee	21-10-28	CI
Medivir AB Appoints Jens Lindberg as CEO	21-10-25	CI
Medivir AB Announces Resignation of Helena Levander and Bengt Julander from Board of Directors	21-05-05	CI
Medivir AB Announces Executive Changes	21-04-16	CI
Medivir AB Announces the Resignation of Yilmaz Mahshid as CEO of the Company	21-03-22	CI

No results for this search